2019 Medical Devices Pipeline Assessment on Hemostasis Tests - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Hemostasis Tests - Medical Devices Pipeline Assessment, 2019" report has been added to ResearchAndMarkets.com's offering.

This report provides an overview of Hemostasis Tests currently in the pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Hemostasis Tests pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by a team of industry experts.

Scope

• Extensive coverage of the Hemostasis Tests under development
• The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
• The report reviews the major players involved in the development of Hemostasis Tests and list all their pipeline projects
• The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
• The report provides key clinical trial data of ongoing trials specific to pipeline products
• Recent developments in the segment/industry

Reasons to buy

• Formulate significant competitor information, analysis, and insights to improve R&D strategies
• Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
• Identify and understand important and diverse types of Hemostasis Tests under development
• Develop market-entry and market expansion strategies
• Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
• In-depth analysis of the product's current stage of development, territory and estimated launch date

Key Topics Covered:

1 Introduction

1.1 Hemostasis Tests Overview

2 Products under Development

2.1 Hemostasis Tests - Pipeline Products by Stage of Development

2.2 Hemostasis Tests - Pipeline Products by Segment

2.3 Hemostasis Tests - Pipeline Products by Territory

2.4 Hemostasis Tests - Pipeline Products by Regulatory Path

2.5 Hemostasis Tests - Pipeline Products by Estimated Approval Date

3 Hemostasis Tests - Pipeline Products under Development by Companies

3.1 Hemostasis Tests Companies - Pipeline Products by Stage of Development

3.2 Hemostasis Tests - Pipeline Products by Stage of Development

4 Hemostasis Tests Companies and Product Overview

5 Hemostasis Tests- Recent Developments

6 Appendix

Companies Mentioned

• Alere Inc
• Analyticon Biotechnologies AG
• Atantares Corp
• Atomo Diagnostics Pty Ltd
• BioMedica USA LLC (Inactive)
• Braun Biosystems, Inc. (Inactive)
• Carclo Diagnostic Solutions Ltd
• Cascade Metrix LLC
• Diagnostica Stago Inc
• Edan Instruments Inc
• EKF Diagnostics Holdings Plc
• ELITechGroup Inc
• Emosis SAS
• Fraunhofer Institute for Cell Therapy and Immunology
• Grifols SA
• Hansjorg Wyss Institute for Biologically Inspired Engineering
• Helena Laboratories Corp
• HemoSonics LLC
• Instrumentation Laboratory Co
• Levisonics Inc
• Massachusetts General Hospital
• Novametics Inc (Inactive)
• Ortho-Clinical Diagnostics Inc
• Pakwa Technologies
• PortaScience Inc
• Radiometer Medical ApS
• Rappaport Family Institute for Research in the Medical Science
• rHealth
• Roche Diagnostics International Ltd
• Sekisui Diagnostics LLC
• Siemens Healthcare Diagnostics GmbH
• Siemens Healthineers AG
• SonoMedix, Inc.
• SQI Diagnostics Inc
• Stichting Lygature
• Tarabios
• The Binding Site Group Ltd
• ThromboTherapeutics Inc
• Transfusion & Transplantation Technologies (Inactive)
• Universal Biosensors Inc
• University of Colorado
• University of Michigan
• University of Texas Health Science Center at Houston
• University of Vermont

For more information about this report visit https://www.researchandmarkets.com/r/xmmuhx